InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Daskal Ilan, 首席财务官. Insider active across 4 companies, notably Natus Medical INC. Cumulatively, 25 filings have been logged. Split: 0 buy · 6 sells. Total volume traded: €3.1m. History available since 11 June 2021. The latest transaction was disclosed on 28 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Daskal Ilan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
55,114 股0Common StockSEC:0000912093-26-000072:0
24,857 股@ US$36.54Common StockSEC:0000912093-26-000072:1
47,420 股0Common StockSEC:0000912093-26-000072:2
21,387 股@ US$36.54Common StockSEC:0000912093-26-000072:3
30,257 股@ US$36.29Common StockSEC:0000912093-26-000074:0
26,033 股@ US$36.29Common StockSEC:0000912093-26-000074:1
25,100 股@ US$17.8436.6% 占其流量Common StockSEC:0000912093-25-000213:0
62,645 股0Common StockSEC:0000912093-25-000207:0
70,545 股0Common StockSEC:0000912093-25-000129:0
55,115 股0Common StockSEC:0000912093-25-000102:0
82,095 股@ US$9.28100.0% 占其流量Common StockSEC:0000912093-25-000075:0
39,783 股0Common StockSEC:0001127602-24-028243:0
694 股0Bio-Rad A Common StockSEC:0001062993-23-017644:0
243 股@ US$466.246.2% 占其流量Bio-Rad A Common StockSEC:0001062993-23-009008:1
700 股0Bio-Rad A Common StockSEC:0001062993-23-009008:0
541 股0Bio-Rad A Common StockSEC:0001062993-22-019274:0
455 股0Bio-Rad A Common StockSEC:0001062993-22-019183:0
18,937 股@ US$33.5063.0% 占其流量Common Stock, $0.001 par value per shareSEC:0000878526-22-000092:0
5,075 股0Common Stock, $0.001 par value per shareSEC:0000878526-22-000041:0
700 股0Bio-Rad A Common StockSEC:0001062993-22-010014:0
270 股@ US$820.0620.8% 占其流量Bio-Rad A Common StockSEC:0001062993-21-008354:0
540 股@ US$524.3026.6% 占其流量Bio-Rad A Common StockSEC:0001062993-21-008242:0
1,400 股@ US$309.8440.9% 占其流量Bio-Rad A Common StockSEC:0001062993-21-007078:0
5,214 股@ US$28.7715.7% 占其流量Common Stock, $0.001 par value per shareSEC:0000878526-21-000061:0
2,500 股@ US$27.467.0% 占其流量Common Stock, $0.001 par vale per shareSEC:0000878526-21-000053:0
25 条申报中的 25 条
About Daskal Ilan
Daskal Ilan is Directeur Financier. He has filed 19 disclosures in total. Across the 19 most recent sampled filings, they cover the period from 2021-06-15 to 2025-12-03, with 0 in purchases and 1916256 in sales, and the most frequent transaction nature is Levée d'options. His listed companies are Bio-Rad Laboratories, INC., where he is EVP, Chief Financial Officer, Viavi Solutions INC., where he is EVP, CFO, and Natus Medical INC, where he is Director.
